Medicare Enrolled
Dr. Sultana Razia, M.D.
Hematology & Oncology · New Hartford, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Razia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Razia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Razia
Dr. Sultana Razia is a hematology & oncology specialist in New Hartford, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Razia performed 214,323 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Razia received a total of $4,590 from 43 pharmaceutical and/or device companies across 319 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Razia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 2% volume in NY
$4,590 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗214,323
Medicare services
Top 2% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
84,200 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
80,250 | $1 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
23,480 | $6 | $22 |
| Denosumab injection (Prolia/Xgeva) | 7,080 | $18 | $33 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
4,606 | $6 | $35 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,940 | $1 | $57 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,250 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,069 | $92 | $202 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
2,063 | $10 | $40 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
999 | $1 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
569 | $64 | $143 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
492 | $110 | $400 |
| Anti-nausea injection (ondansetron/Zofran) | 448 | $0 | $5 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
422 | $96 | $248 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
413 | $21 | $63 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
406 | $27 | $88 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
274 | $15 | $38 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
263 | $47 | $114 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
260 | $1 | $2 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
115 | $29 | $40 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $20 | $58 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
92 | $10 | $30 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
69 | $76 | $82 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
67 | $91 | $170 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
55 | $66 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $132 | $329 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $128 | $284 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $114 | $265 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
37 | $17 | $44 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $12 | $40 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
35 | $1 | $4 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
32 | $44 | $125 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
21 | $25 | $93 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
18 | $32 | $55 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
17 | $72 | $78 |
| New patient office visit, complex (60-74 min) | 15 | $156 | $335 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
38.1% high complexity
60.4% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,590
Total received (2018-2024)
Avg $765/year across 6 years
Top 36% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
319
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$94
2023
$129
2022
$105
2020
$716
2019
$1,804
2018
$1,741
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$42
Roche Diagnostics Corporation
$35
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$477
Novartis Pharmaceuticals Corporation
$473
Janssen Biotech, Inc.
$439
Genentech USA, Inc.
$428
PFIZER INC.
$304
Pharmacyclics LLC, An AbbVie Company
$232
Alexion Pharmaceuticals, Inc.
$224
Merck Sharp & Dohme Corporation
$171
Seattle Genetics, Inc.
$168
Aurobindo Pharma USA, Inc.
$135
AstraZeneca Pharmaceuticals LP
$133
Janssen Pharmaceuticals, Inc
$116
Sunovion Pharmaceuticals Inc.
$105
Amgen Inc.
$93
Astellas Pharma US Inc
$77
Incyte Corporation
$71
Gilead Sciences, Inc.
$70
Sirtex Medical Inc
$69
Lilly USA, LLC
$69
Kyowa Kirin, Inc.
$65
Celgene Corporation
$61
AbbVie, Inc.
$61
Karyopharm Therapeutics Inc.
$51
Agios Pharmaceuticals, Inc.
$49
Lexicon Pharmaceuticals, Inc.
$38
Midatech Pharma US Inc
$36
Clovis Oncology, Inc.
$36
Roche Diagnostics Corporation
$35
EMD Serono, Inc.
$31
Apellis Pharmaceuticals, Inc.
$30
Ipsen Biopharmaceuticals, Inc
$30
Taiho Oncology, Inc.
$26
Octapharma USA, Inc.
$26
Jazz Pharmaceuticals Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$17
Regeneron Healthcare Solutions, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
HOSPIRA, INC.
$16
Rigel Pharmaceuticals, Inc.
$15
Heron Therapeutics, Inc.
$15
Seagen Inc.
$13
Exelixis Inc.
$12
Foundation Medicine, Inc.
$11
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Avastin · BOSULIF · Bavencio · CHANTIX · CINVANTI · CYRAMZA · Cabometyx · Creon · DARZALEX · ELIGARD · ELIQUIS · EMPLICITI · ERBITUX · ERLEADA · Empaveli · Erleada · FARESTON · FOUNDATIONONE · Folotyn · GAZYVA · Gelclair · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · Inrebic · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · Lonsurf · Lupron · Lupron Depot · MEKINIST · Neulasta · OPDIVO · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Perjeta · Prolia · RETACRIT · RYBREVANT · RYDAPT · Revlimid · Rituxan · Rubraca · SANDOSTATIN · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · TASIGNA · TECENTRIQ · TIBSOVO · Tavalisse · ULTOMIRIS · VENCLEXTA · VOTRIENT · VYXEOS · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · YERVOY · ZERBAXA · ZYTIGA · Zuplenz
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
6
County median income
$68,819
Nearest hospital to ZIP centroid (approximate)
MOHAWK VALLEY PSYCHIATRIC CENTER
8.2 mi
8.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Razia is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Razia experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Razia performed 84,200 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Razia receive payments from pharmaceutical companies?
Yes. Dr. Razia received a total of $4,590 from 43 companies across 319 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Razia's costs compare to other hematology & oncology specialists in New Hartford?
Dr. Razia's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Razia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in New Hartford
Browse hematology & oncology specialists in New Hartford ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology